1. Home
  2. IRWD vs CIK Comparison

IRWD vs CIK Comparison

Compare IRWD & CIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRWD
  • CIK
  • Stock Information
  • Founded
  • IRWD 1998
  • CIK 1987
  • Country
  • IRWD United States
  • CIK United States
  • Employees
  • IRWD N/A
  • CIK N/A
  • Industry
  • IRWD Biotechnology: Pharmaceutical Preparations
  • CIK Finance/Investors Services
  • Sector
  • IRWD Health Care
  • CIK Finance
  • Exchange
  • IRWD Nasdaq
  • CIK Nasdaq
  • Market Cap
  • IRWD 150.9M
  • CIK 154.6M
  • IPO Year
  • IRWD 2010
  • CIK N/A
  • Fundamental
  • Price
  • IRWD $0.63
  • CIK $2.86
  • Analyst Decision
  • IRWD Buy
  • CIK
  • Analyst Count
  • IRWD 5
  • CIK 0
  • Target Price
  • IRWD $4.94
  • CIK N/A
  • AVG Volume (30 Days)
  • IRWD 3.0M
  • CIK 115.4K
  • Earning Date
  • IRWD 05-07-2025
  • CIK 01-01-0001
  • Dividend Yield
  • IRWD N/A
  • CIK 9.03%
  • EPS Growth
  • IRWD N/A
  • CIK N/A
  • EPS
  • IRWD N/A
  • CIK N/A
  • Revenue
  • IRWD $317,676,000.00
  • CIK N/A
  • Revenue This Year
  • IRWD N/A
  • CIK N/A
  • Revenue Next Year
  • IRWD N/A
  • CIK N/A
  • P/E Ratio
  • IRWD N/A
  • CIK N/A
  • Revenue Growth
  • IRWD N/A
  • CIK N/A
  • 52 Week Low
  • IRWD $0.53
  • CIK $2.50
  • 52 Week High
  • IRWD $7.11
  • CIK $3.19
  • Technical
  • Relative Strength Index (RSI)
  • IRWD 39.10
  • CIK 51.71
  • Support Level
  • IRWD $0.55
  • CIK $2.85
  • Resistance Level
  • IRWD $0.65
  • CIK $2.92
  • Average True Range (ATR)
  • IRWD 0.07
  • CIK 0.04
  • MACD
  • IRWD 0.02
  • CIK 0.00
  • Stochastic Oscillator
  • IRWD 37.04
  • CIK 50.14

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

About CIK Credit Suisse Asset Management Income Fund Inc.

Credit Suisse Asset Mgmt Income Fund Inc is a closed-end management investment company. The investment objective of the fund is to provide current income consistent with the preservation of capital. Credit Suisse serves as an investment adviser for the fund. Asset Management offers a wide range of investment products and functions across asset classes and investment styles. The division manages various regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations and individuals.

Share on Social Networks: